Engineered blood vessel cells boost islet transplant success in diabetes treatment
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators. The new…
Read More...
Read More...